Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

Tandem repeats significantly influence hair color, especially darker shades, across different ancestries.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Robotic-assisted hair transplant is effective and less painful, but needs more evaluation for long-term results.

Reflectance confocal microscopy can noninvasively diagnose onychomatricoma by showing unique features different from healthy nails or nail fungus.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Women with thyroid disease are more likely to experience female pattern hair loss, especially if they've had thyroid disease for a long time.

Some people have severe allergic reactions to anthelminthic drugs, but these are often due to the parasites, not the drugs.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

New methods improve how we test hair growth treatments, but challenges like slow hair changes and high costs remain.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Finasteride affects alcohol intake in male mice, possibly due to neurosteroids.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Researchers developed a mouse model that successfully mimics the bladder damage seen in humans after radiation therapy.

Polyamines are important for hair growth, but more research is needed to understand their functions and treatment potential.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Deoxycholic acid is effective for reducing chin fat but can cause side effects and serious complications, so careful patient evaluation is needed.

Many patients on new leukemia drugs had mild to moderate skin reactions.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

Consider benefits and risks of new alopecia treatments for safety.

New treatments are available for managing ingrown hair inflammation.